Skip to main navigation
ANI Pharmaceuticals, Inc.
  • About
    Executive Team Board of Directors
    How We Operate
    Quality Capabilities
    Locations News
  • Products
  • Contract Manufacturing
  • Investors
  • We're Hiring
    We're Hiring Career Benefits Job Openings Open Commercial Positions Employment Application Where We Live
  • Contact
    Contact Us Locations

News

Investors Menu
  • Overview
  • News
  • Events & Presentations
  • Stock Information
    Stock Quote & Chart Investment Calculator Analyst Coverage
  • Financials
    Quarterly Results Annual Reports SEC Filings
  • Governance
    Governance Documents Executive Management Board of Directors Committee Composition
  • Resources
    Investor FAQs Information Request Form Investor Email Alerts Investor Contacts
09/18/2023
ANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023
09/12/2023
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Tablets USP
08/28/2023
ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.1%
08/24/2023
ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
08/23/2023
ANI Pharmaceuticals Appoints Healthcare Executive Matthew J. Leonard to its Board of Directors
08/09/2023
ANI Pharmaceuticals Reports Record Second Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance  
07/31/2023
ANI Pharmaceuticals to Discuss Second Quarter 2023 Financial Results on August 9, 2023, at 8:30 a.m. ET
05/22/2023
ANI Pharmaceuticals to Present at the Jefferies Healthcare Conference
05/16/2023
ANI Pharmaceuticals Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
05/15/2023
ANI Pharmaceuticals Announces FDA Approval and Commercialization of Two ANDAs with CGT Exclusivity

Pagination

  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 19

Contact Us

INVESTOR CONTACT

In-Site Communications, Inc.
Lisa M. Wilson

212-452-2793
envelope iconIR@anipharmaceuticals.com

Quick Links

  • SEC Filings
  • Investor FAQs
  • Information Request Form
Unsubscribe
ANI Pharmaceuticals, Inc.
Products | Investors | Careers | Contact Us | Privacy Policy | Terms of Use | Accessibility
© Copyright 2023 ANI Pharmaceuticals, Inc.
Linkedin Youtube